ERS Genomics was formed to provide broad access to CRISPR-Cas9 intellectual property held by Dr. Emmanuelle Charpentier, co-inventor and co-owner. Licenses are available to companies for internal research and sale of products and services.
Timeline
People
Name
Role
LinkedIn
Emmanuelle Charpentier
Co-founder
Shaun Foy
Co-founder
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
Alex Keown
December 3, 2020
BioSpace
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.